Pain Therapeutics Inc (PTIE) - Financial and Strategic SWOT Analysis Review

Pain Therapeutics Inc (PTIE) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH32079FSA
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pain Therapeutics Inc (PTIE)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Pain Therapeutics Inc (Pain Therapeutics) is a biopharmaceutical company which focuses on the development and commercialization of novel drugs for treating central nervous system disorders such as chronic pain. The company employs patented abuse-deterrent formulations (ADFs) for the treatment of pain. Its lead drug candidate, Remoxy (oxycodone) is a proprietary, abuse-deterrent, oral formulation of oxycodone (CII) that provides twelve hours of steady pain relief. The company is also developing an abuse-deterrent fentanyl skin patch to treat severe pain, a blood-based diagnostic to detect Alzheimer's disease (AD), and a proprietary small molecule drug for the treatment of AD. Pain Therapeutics is headquartered in Austin, Texas, the US.

Pain Therapeutics Inc Key Recent Developments

May 09,2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER

Feb 05,2018: Pain Therapeutics Reports Financial Results For 2017

Nov 01,2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results

Aug 09,2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update

Apr 25,2017: Pain Therapeutics Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Pain Therapeutics Inc-Key Facts 5

Pain Therapeutics Inc-Key Employees 6

Pain Therapeutics Inc-Key Employee Biographies 7

Pain Therapeutics Inc-Major Products and Services 8

Pain Therapeutics Inc-History 9

Pain Therapeutics Inc-Company Statement 11

Pain Therapeutics Inc-Locations And Subsidiaries 12

Head Office 12

Section 2-Company Analysis 13

Company Overview 13

Pain Therapeutics Inc-Business Description 14

Pain Therapeutics Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Pain Therapeutics Inc-Strengths 15

Pain Therapeutics Inc-Weaknesses 16

Pain Therapeutics Inc-Opportunities 17

Pain Therapeutics Inc-Threats 18

Pain Therapeutics Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Recent Developments 26

May 09, 2018: Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY ER 26

Nov 01, 2017: Pain Therapeutics Reports Third Quarter 2017 Financial Results 27

Aug 09, 2017: Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update 28

Apr 25, 2017: Pain Therapeutics Reports First Quarter 2017 Financial Results 30

Feb 17, 2017: Pain Therapeutics Reports 2016 Financial Results 31

Section 5-Appendix 32

Methodology 32

Ratio Definitions 32

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Figures

Pain Therapeutics Inc, Performance Chart (2013-2017) 23

Pain Therapeutics Inc, Ratio Charts 25

List of Tables

Pain Therapeutics Inc, Key Facts 5

Pain Therapeutics Inc, Key Employees 6

Pain Therapeutics Inc, Key Employee Biographies 7

Pain Therapeutics Inc, Major Products and Services 8

Pain Therapeutics Inc, History 9

Pain Therapeutics Inc, Key Competitors 19

Pain Therapeutics Inc, Ratios based on current share price 20

Pain Therapeutics Inc, Annual Ratios 21

Pain Therapeutics Inc, Annual Ratios (Cont...1) 22

Pain Therapeutics Inc, Interim Ratios 24

Currency Codes 32

Capital Market Ratios 32

Equity Ratios 33

Profitability Ratios 33

Cost Ratios 34

Liquidity Ratios 34

Leverage Ratios 35

Efficiency Ratios 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Alternative technologies

Teva Pharmaceutical Industries Ltd

Roxane Laboratories Inc

Elkins-Sinn Inc

Endo Pharmaceuticals Inc

Purdue Pharma LP

Hikma Pharmaceuticals Plc

Pain Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8625
Site License
USD 250 INR 17250
Corporate User License
USD 375 INR 25875



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]